Sisir Bhattacharya

Title: Sisir Bhattacharya: A Pioneer in Crystalline Pharmaceutical Innovations

Introduction

Sisir Bhattacharya, a dedicated inventor based in Commack, NY, has made significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, he has focused on developing innovative crystalline forms that promise to enhance the effectiveness of antibacterial treatments.

Latest Patents

His latest patents revolve around the crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt, commonly known as NXL-104. This invention details novel crystalline forms of the sodium salt and compositions that include these forms, used alone or in combination with antibacterial agents such as ceftaroline fosamil. Both patents describe the processes for preparing these crystalline forms and their methods of application in treating bacterial infections, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Sisir Bhattacharya has collaborated with various pharmaceutical companies, notably Forest Laboratories Holdings Limited. His work in these esteemed institutions has allowed him to bridge research with practical applications, highlighting his impactful role in the industry.

Collaborations

Sisir has had the opportunity to work alongside notable colleagues, including Mahendra G. Dedhiya and Véronique Ducandas. These collaborations have enriched his research efforts and contributed to the successful development of his inventions.

Conclusion

Sisir Bhattacharya's innovative spirit and dedication to research underscore the importance of his contributions to the pharmaceutical field. Through his patents and collaborations, he continues to pave the way for advancements in treatment methodologies, demonstrating the vital role of inventors in improving healthcare outcomes.